berberine has been researched along with Amyloid Deposits in 6 studies
Excerpt | Relevance | Reference |
---|---|---|
"Additionally, the ratio of β-amyloid plaques and the number of activated microglia were evaluated by immunofluorescence staining." | 1.91 | An Exosome-Based Therapeutic Strategy Targeting Neuroinflammation in Alzheimer's Disease with Berberine and Palmatine. ( Ge, P; Guo, R; Guo, S; Lei, S; Qi, Y; Wang, N; Wei, X; Wu, W; Xiao, Q; Yang, N; Zhang, Q; Zhao, L; Zhao, X; Zhou, P; Zhu, H, 2023) |
"Berberine (BBR) plays a neuroprotective role in the pathogenesis of Alzheimer's disease (AD), inhibiting amyloid-β (Aβ) production and promoting Aβ clearance." | 1.62 | Ameliorating Ribosylation-Induced Amyloid-β Pathology by Berberine via Inhibiting mTOR/p70S6K Signaling. ( Cai, ZY; Huang, ZT; Li, J; Wang, YY; Wu, LQ; Yan, Q; Yuan, MH; Zou, Q, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Zhao, X | 1 |
Ge, P | 1 |
Lei, S | 1 |
Guo, S | 1 |
Zhou, P | 1 |
Zhao, L | 1 |
Qi, Y | 1 |
Wei, X | 1 |
Wu, W | 1 |
Wang, N | 1 |
Guo, R | 1 |
Yang, N | 1 |
Xiao, Q | 1 |
Zhang, Q | 1 |
Zhu, H | 1 |
Wang, S | 1 |
Jiang, W | 1 |
Ouyang, T | 1 |
Shen, XY | 1 |
Wang, F | 1 |
Qu, YH | 1 |
Zhang, M | 1 |
Luo, T | 1 |
Wang, HQ | 1 |
Wang, YY | 1 |
Yan, Q | 1 |
Huang, ZT | 1 |
Zou, Q | 1 |
Li, J | 1 |
Yuan, MH | 1 |
Wu, LQ | 1 |
Cai, ZY | 1 |
Durairajan, SS | 1 |
Huang, YY | 1 |
Yuen, PY | 1 |
Chen, LL | 1 |
Kwok, KY | 1 |
Liu, LF | 1 |
Song, JX | 1 |
Han, QB | 1 |
Xue, L | 1 |
Chung, SK | 1 |
Huang, JD | 1 |
Baum, L | 1 |
Senapati, S | 1 |
Li, M | 1 |
Yu, D | 1 |
Tao, BB | 1 |
Yang, YY | 1 |
Du, LS | 1 |
Yang, SS | 1 |
He, XJ | 1 |
Zhu, YW | 1 |
Yan, JK | 1 |
Yang, Q | 1 |
Huang, M | 1 |
Jiang, X | 1 |
Liang, Y | 1 |
Liu, Q | 1 |
Chen, S | 1 |
Guo, Y | 1 |
6 other studies available for berberine and Amyloid Deposits
Article | Year |
---|---|
An Exosome-Based Therapeutic Strategy Targeting Neuroinflammation in Alzheimer's Disease with Berberine and Palmatine.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Berberine; Cytokines; Exosomes; Mice; Neuroinflam | 2023 |
Jatrorrhizine Balances the Gut Microbiota and Reverses Learning and Memory Deficits in APP/PS1 transgenic mice.
Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; Astrocytes; Berberine; DNA, Ribosomal; Gastroi | 2019 |
Ameliorating Ribosylation-Induced Amyloid-β Pathology by Berberine via Inhibiting mTOR/p70S6K Signaling.
Topics: Animals; Berberine; Blotting, Western; Brain; Fluorescent Antibody Technique; Mice; Mice, Transgenic | 2021 |
Effects of Huanglian-Jie-Du-Tang and its modified formula on the modulation of amyloid-β precursor protein processing in Alzheimer's disease models.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Berberine; Cell Survival; Disease Models | 2014 |
The IDO inhibitor coptisine ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Berberine; Brain; Cell Survival; Cogniti | 2015 |
Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Ac | 2017 |